Vir Biotechnology Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$11.30

-0.45 (-3.83%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 13 93%

Hold 1 7%

Sell 0 0%

Price Target

Analyst Price Target +50.3% upside

Low Target $13.41

Average Target $16.98

High Target $22.24

Current Price $11.30

Current
$11.30

Target
$16.98

$13.41 $16.98 avg $22.24

Scenario Analysis

Bear Case

$13.41

18.7%

Low target

Base Case

$16.98

+50.3%

Avg target

Bull Case

$22.24

+96.8%

High target

Risk/Reward

5.2x

Highly favorable

Price in Context

52-Week High

$12.19

-7.3% from high

52-Week Low

$4.82

+134.7% from low

Target vs 52W High

$16.98

+39.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-10.6%
AMGN Amgen Inc	Hold	42	43%	$190.87	-58.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+116.4%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-19.2%
MRNA Moderna Inc	Hold	31	35%	$149.45	-38.1%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-91.5%
NTRA Natera Inc	Strong Buy	30	90%	$142.91	-60.7%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-35.8%